Aclacinomycin A and etoposide (VP-16-213): An effective regimen in previously treated patients with refractory acute myelogenous leukemia

J. M. Rowe, A. Y.C. Chang, J. M. Bennett

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Aclacinomycin A and etoposide (VP-16-213): An effective regimen in previously treated patients with refractory acute myelogenous leukemia'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences